Locations:
Search IconSearch

Research

690×380-Pioro-Pseudobulbar
July 24, 2014/Neurosciences/Research

No Laughing Matter: Defining the Role of a New Agent for Pseudobulbar Affect

Exploring new uses of first approved therapy for PBA

690×380
July 14, 2014/Neurosciences/Research

Recombinant Human Bone Morphogenetic Protein-2: Friend or Foe?

Jury’s still out on this osteoinductive glycoprotein

Alz-690×380
July 2, 2014/Neurosciences/Research

New Analysis Highlights Urgent Need for Alzheimer’s Disease Drug Development

Pipeline for therapeutics is small; 99.6 percent of drug attempts fail

BackPage 21 of 21Next

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad